As shown in Fig. 4G, the IF assay indicated that BARX1 was overexpressed and associated with HSPA6 overexpression in OS tumour tissues, which revealed the regulatory effect of BARX1 on HSPA6 from a clinical perspective. The gene discussed is BARX1; the disease is neoplasm.